Κλάδος Επιχείρησης: ΦΑΡΜΑΤΕΝ ΑΝΩΝΥΜΟΣ ΒΙΟΜΗΧΑΝΙΚΗ ΚΑΙ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ-ΙΑΤΡΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΙΟΝΤΩΝ
Σύντομη Περιγραφή: Founded in 1969, Pharmathen has grown to become one of the largest, vertically integrated developers of complex drug delivery technologies and is among the top 50 pharmaceutical research companies in Europe. With best-in-class research & development capabilities, the company specializes in one of the most extensive and advanced pipelines of long-acting injectables (LAI), sustained release and ophthalmic formulations. Pharmathen’s highly diversified portfolio consists of over 90 commercialized products, is produced in its US FDA and EU approved manufacturing facilities in Greece, is sold to 250 customers and accessed by patients in more than 90 countries worldwide. Pharmathen is one of the largest private investors in research and development in Greece, with steady investments of €35 million annually in the R&D sector and employs more than 1.450 people from over 24 different nationalities. The company's enduring success is attributed to the passion for creativity, the ethics, and dedication of its people, who share the same values and remain committed to the company's vision of making a difference in people’s lives.
Διεύθυνση: Dervenakion
Αριθμός: 6
Ταχ. Κώδικας: 15351
Πόλη: Pallini, Athens
Τηλέφωνα Επικοινωνίας: 2160040134
Email: info@pharmathen.com
URL: https://www.pharmathen.com/
Δημόσια εμφάνιση στοιχείων: Ναι
